- Home
- CTNT vs XBIO Comparison
CTNT vs XBIO Comparison
Compare CTNT & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- XBIO
- Stock Information
- Founded
- CTNT 2016
- XBIO N/A
- Country
- CTNT United States
- XBIO United States
- Employees
- CTNT N/A
- XBIO N/A
- Industry
- CTNT
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- XBIO Health Care
- Exchange
- CTNT Nasdaq
- XBIO Nasdaq
- Market Cap
- CTNT 6.5M
- XBIO 5.8M
- IPO Year
- CTNT 2023
- XBIO N/A
- Fundamental
- Price
- CTNT $1.37
- XBIO $2.46
- Analyst Decision
- CTNT Hold
- XBIO Hold
- Analyst Count
- CTNT 1
- XBIO 1
- Target Price
- CTNT N/A
- XBIO N/A
- AVG Volume (30 Days)
- CTNT 15.2K
- XBIO 6.6K
- Earning Date
- CTNT 05-12-2025
- XBIO 03-18-2025
- Dividend Yield
- CTNT N/A
- XBIO N/A
- EPS Growth
- CTNT N/A
- XBIO N/A
- EPS
- CTNT N/A
- XBIO N/A
- Revenue
- CTNT $455,805.00
- XBIO $2,500,284.00
- Revenue This Year
- CTNT $258.05
- XBIO N/A
- Revenue Next Year
- CTNT N/A
- XBIO $27.78
- P/E Ratio
- CTNT N/A
- XBIO N/A
- Revenue Growth
- CTNT N/A
- XBIO N/A
- 52 Week Low
- CTNT $1.25
- XBIO $2.45
- 52 Week High
- CTNT $236.16
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- CTNT 27.79
- XBIO 17.66
- Support Level
- CTNT $1.25
- XBIO $3.25
- Resistance Level
- CTNT $1.93
- XBIO $3.43
- Average True Range (ATR)
- CTNT 0.13
- XBIO 0.24
- MACD
- CTNT -0.01
- XBIO -0.08
- Stochastic Oscillator
- CTNT 17.70
- XBIO 0.71
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the China market. The parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers' official distribution systems. The company purchases automobiles, luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to customers, including both U.S. and PRC parallel-import car dealers. The company derives profits from the price difference between buying and selling prices for parallel-import vehicles.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.